Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)

NCT07317102 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.

NCT NCT07317102
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07317102 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
Lead sponsor
Insulet Corporation
Phase
Observational
Overall status
Recruiting
Start date
March 16, 2026
Completion date
November 30, 2027
Enrollment
152 (estimated)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes, diabetes mellitus, type 1 diabetes